|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to adding certain synthetic cannabinoids to Penalty Group |
|
2 of the Texas Controlled Substances Act. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 481.103(a), Health and Safety Code, is |
|
amended to read as follows: |
|
(a) Penalty Group 2 consists of: |
|
(1) any quantity of the following hallucinogenic |
|
substances, their salts, isomers, and salts of isomers, unless |
|
specifically excepted, if the existence of these salts, isomers, |
|
and salts of isomers is possible within the specific chemical |
|
designation: |
|
alpha-ethyltryptamine; |
|
alpha-methyltryptamine; |
|
4-bromo-2, 5-dimethoxyamphetamine (some trade or |
|
other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; |
|
4-bromo-2, 5-DMA); |
|
4-bromo-2, 5-dimethoxyphenethylamine; |
|
Bufotenine (some trade and other names: 3-(beta- |
|
Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- |
|
indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- |
|
dimethyltryptamine; mappine); |
|
Diethyltryptamine (some trade and other |
|
names: N, N-Diethyltryptamine, DET); |
|
2, 5-dimethoxyamphetamine (some trade or other |
|
names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); |
|
2, 5-dimethoxy-4-ethylamphetamine (trade or other |
|
name: DOET); |
|
2, 5-dimethoxy-4-(n)-propylthiophenethylamine |
|
(trade or other name: 2C-T-7); |
|
Dimethyltryptamine (trade or other name: DMT); |
|
Dronabinol (synthetic) in sesame oil and |
|
encapsulated in a soft gelatin capsule in a U.S. Food and Drug |
|
Administration approved drug product (some trade or other names for |
|
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- |
|
trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- |
|
(trans)- tetrahydrocannabinol); |
|
Ethylamine Analog of Phencyclidine (some trade or |
|
other names: N-ethyl-1-phenylcyclohexylamine, (1- |
|
phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, |
|
cyclohexamine, PCE); |
|
Ibogaine (some trade or other names: 7-Ethyl-6, |
|
6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- |
|
pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); |
|
Mescaline; |
|
5-methoxy-N, N-diisopropyltryptamine; |
|
5-methoxy-3, 4-methylenedioxy amphetamine; |
|
4-methoxyamphetamine (some trade or other |
|
names: 4-methoxy-alpha-methylphenethylamine; |
|
paramethoxyamphetamine; PMA); |
|
1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, |
|
PPMP); |
|
4-methyl-2, 5-dimethoxyamphetamine (some trade |
|
and other names: 4-methyl-2, 5-dimethoxy-alpha- |
|
methylphenethylamine; "DOM"; "STP"); |
|
3,4-methylenedioxy methamphetamine (MDMA, MDM); |
|
3,4-methylenedioxy amphetamine; |
|
3,4-methylenedioxy N-ethylamphetamine (Also |
|
known as N-ethyl MDA); |
|
Nabilone (Another name for nabilone: (+)-trans- |
|
3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, |
|
6-dimethyl-9H-dibenzo[b,d] pyran-9-one; |
|
N-benzylpiperazine (some trade or other |
|
names: BZP; 1-benzylpiperazine); |
|
N-ethyl-3-piperidyl benzilate; |
|
N-hydroxy-3,4-methylenedioxyamphetamine (Also |
|
known as N-hydroxy MDA); |
|
4-methylaminorex; |
|
N-methyl-3-piperidyl benzilate; |
|
Parahexyl (some trade or other names: 3-Hexyl-1- |
|
hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] |
|
pyran; Synhexyl); |
|
1-Phenylcyclohexylamine; |
|
1-Piperidinocyclohexanecarbonitrile (PCC); |
|
Psilocin; |
|
Psilocybin; |
|
Pyrrolidine Analog of Phencyclidine (some trade |
|
or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); |
|
Tetrahydrocannabinols, other than marihuana, and |
|
synthetic equivalents of the substances contained in the plant, or |
|
in the resinous extractives of Cannabis, or synthetic substances, |
|
derivatives, and their isomers with similar chemical structure and |
|
pharmacological activity such as: |
|
delta-1 cis or trans tetrahydrocannabinol, |
|
and their optical isomers; |
|
delta-6 cis or trans tetrahydrocannabinol, |
|
and their optical isomers; |
|
delta-3, 4 cis or trans |
|
tetrahydrocannabinol, and its optical isomers; |
|
compounds of these structures, regardless of |
|
numerical designation of atomic positions, since nomenclature of |
|
these substances is not internationally standardized; |
|
Thiophene Analog of Phencyclidine (some trade or |
|
other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl |
|
Analog of Phencyclidine; TPCP, TCP); |
|
1-pyrrolidine (some trade or other name: TCPy); |
|
1-(3-trifluoromethylphenyl)piperazine (trade or |
|
other name: TFMPP); and |
|
3,4,5-trimethoxy amphetamine; |
|
(2) Phenylacetone (some trade or other |
|
names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl |
|
ketone); [and] |
|
(3) unless specifically excepted or unless listed in |
|
another Penalty Group, a material, compound, mixture, or |
|
preparation that contains any quantity of the following substances |
|
having a potential for abuse associated with a depressant or |
|
stimulant effect on the central nervous system: |
|
Aminorex (some trade or other |
|
names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- |
|
phenyl-2-oxazolamine); |
|
Amphetamine, its salts, optical isomers, and |
|
salts of optical isomers; |
|
Cathinone (some trade or other names: 2-amino-1- |
|
phenyl-1-propanone, alpha-aminopropiophenone, 2- |
|
aminopropiophenone); |
|
Etorphine Hydrochloride; |
|
Fenethylline and its salts; |
|
Lisdexamfetamine, including its salts, isomers, |
|
and salts of isomers; |
|
Mecloqualone and its salts; |
|
Methaqualone and its salts; |
|
Methcathinone (some trade or other names: 2- |
|
methylamino-propiophenone; alpha-(methylamino)propriophenone; |
|
2-(methylamino)-1-phenylpropan-1-one; alpha-N- |
|
methylaminopropriophenone; monomethylpropion; ephedrone, N- |
|
methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR |
|
1431); |
|
N-Ethylamphetamine, its salts, optical isomers, |
|
and salts of optical isomers; and |
|
N,N-dimethylamphetamine (some trade or other |
|
names: N,N,alpha-trimethylbenzeneethaneamine; |
|
N,N,alpha-trimethylphenethylamine), its salts, optical isomers, |
|
and salts of optical isomers; and |
|
(4) any quantity of a synthetic chemical compound that |
|
is a cannabinoid receptor agonist and mimics the pharmacological |
|
effect of naturally occurring cannabinoids, including: |
|
naphthoylindoles structurally derived from |
|
3-(1-naphthoyl)indole by substitution at the nitrogen atom of the |
|
indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, |
|
or 2-(4-morpholinyl)ethyl, whether or not further substituted in |
|
the indole ring to any extent, whether or not substituted in the |
|
napthyl ring to any extent, including: |
|
JWH-004; |
|
JWH-007; |
|
JWH-009; |
|
JWH-015; |
|
JWH-016; |
|
JWH-018; |
|
JWH-019; |
|
JWH-020; |
|
JWH-046; |
|
JWH-047; |
|
JWH-048; |
|
JWH-049; |
|
JWH-050; |
|
JWH-070; |
|
JWH-071; |
|
JWH-072; |
|
JWH-073; |
|
JWH-076; |
|
JWH-079; |
|
JWH-080; |
|
JWH-081; |
|
JWH-082; |
|
JWH-094; |
|
JWH-096; |
|
JWH-098; |
|
JWH-116; |
|
JWH-120; |
|
JWH-122; |
|
JWH-148; |
|
JWH-149; |
|
JWH-180; |
|
JWH-181; |
|
JWH-182; |
|
JWH-189; |
|
JWH-193; |
|
JWH-198; |
|
JWH-200; |
|
JWH-210; |
|
JWH-211; |
|
JWH-212; |
|
JWH-213; |
|
JWH-234; |
|
JWH-235; |
|
JWH-236; |
|
JWH-239; |
|
JWH-240; |
|
JWH-241; |
|
JWH-242; |
|
JWH-262; |
|
JWH-386; |
|
JWH-387; |
|
JWH-394; |
|
JWH-395; |
|
JWH-397; |
|
JWH-398; |
|
JWH-399; |
|
JWH-400; |
|
JWH-412; |
|
JWH-413; |
|
JWH-414; and |
|
JWH-415; |
|
naphthylmethylindones structurally derived from |
|
1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen |
|
atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, |
|
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further |
|
substituted in the indole ring to any extent, whether or not |
|
substituted in the naphthyl ring to any extent, including: |
|
JWH-175; |
|
JWH-184; |
|
JWH-185; |
|
JWH-192; |
|
JWH-194; |
|
JWH-195; |
|
JWH-196; |
|
JWH-197; and |
|
JWH-199; |
|
naphthoylpyrroles structurally derived from |
|
3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the |
|
pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, |
|
or 2-(4-morpholinyl)ethyl, whether or not further substituted in |
|
the pyrrole ring to any extent, whether or not substituted in the |
|
naphthyl ring to any extent, including: |
|
JWH-030; |
|
JWH-145; |
|
JWH-146; |
|
JWH-147; |
|
JWH-150; |
|
JWH-156; |
|
JWH-243; |
|
JWH-244; |
|
JWH-245; |
|
JWH-246; |
|
JWH-292; |
|
JWH-293; |
|
JWH-307; |
|
JWH-308; |
|
JWH-346; |
|
JWH-348; |
|
JWH-363; |
|
JWH-364; |
|
JWH-365; |
|
JWH-367; |
|
JWH-368; |
|
JWH-369; |
|
JWH-370; |
|
JWH-371; |
|
JWH-373; and |
|
JWH-392; |
|
naphthylmethylindenes structurally derived from |
|
1-(1-naphthylmethyl)indene by substitution at the 3-position of |
|
the indene ring by alkyl, alkenyl, cycloalkylmethyl, |
|
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further |
|
substituted in the indene ring to any extent, whether or not |
|
substituted in the naphthyl ring to any extent, including JWH-176; |
|
phenylacetylindoles structurally derived from |
|
3-phenylacetylindole by substitution at the nitrogen atom of the |
|
indole ring with alkyl, alkenyl, cycloalkylmethyl, |
|
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further |
|
substituted in the indole ring to any extent, whether or not |
|
substituted in the phenyl ring to any extent, including: |
|
JWH-167; |
|
JWH-201; |
|
JWH-202; |
|
JWH-203; |
|
JWH-204; |
|
JWH-205; |
|
JWH-206; |
|
JWH-207; |
|
JWH-208; |
|
JWH-209; |
|
JWH-237; |
|
JWH-248; |
|
JWH-249; |
|
JWH-250; |
|
JWH-251; |
|
JWH-252; |
|
JWH-253; |
|
JWH-302; |
|
JWH-303; |
|
JWH-304; |
|
JWH-305; |
|
JWH-306; |
|
JWH-311; |
|
JWH-312; |
|
JWH-313; |
|
JWH-314; |
|
JWH-315; and |
|
JWH-316; |
|
cyclohexylphenols structurally derived from |
|
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of |
|
the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, |
|
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not |
|
substituted in the cyclohexyl ring to any extent, including: |
|
CP-55,940; |
|
CP-47,497; and |
|
analogues of CP-47,497, including VII, V, |
|
VIII, I, II, III, IV, IX, X, XI, XII, XIII, XV, and XVI; and |
|
cannabinol derivatives, except where contained in |
|
cannabis or cannabis resin, including tetrahydro derivatives of |
|
cannabinol and 3-alkyl homologues of cannabinol or of its |
|
tetrahydro derivatives, such as: |
|
delta-9-THC; |
|
delta-8-THC; |
|
Nabilone; |
|
HU-210; |
|
HU-211; and |
|
WIN-55,212-2. |
|
SECTION 2. This Act takes effect September 1, 2011. |